Emergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan

Similar documents
Therapy for Acute Stroke. Systems of Care for TIA

AHA/ASA Scientific Statement

Vertebrobasilar Insufficiency

TIA triage in Not all that glitters is gold

44TH ANNUAL RECENT ADVANCES IN NEUROLOGY

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

TIA. What it is, What it isn t, What to do about it, and When WM. BLAINE BENDURE, MD, MS BOARD CERTIFIED NEUROLOGIST

The annual incidence of TIA in the United States is

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

TIA: Updates and Management 2008

How do we assess risk in TIA?

Three months prognosis of transient ischemic attack (TIA) in Erbil Governorate

Transient ischemic attack (TIA) is associated with a high risk

Background. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association

TRANSIENT ISCHEMIC ATTACK (TIA)

ORIGINAL CONTRIBUTION. Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis

Early Hospitalization of Patients with TIA: A Prospective, Population-based Study

Does ABCD 2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack?

David Strain, Diabetes and Vascular Research Centre University of Exeter Medical School, UK

Nicolas Bianchi M.D. May 15th, 2012

Critical Review Form Therapy

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

2018 Update in Diagnosis and Management of Stroke

Can ABCD 2 score predict the need for in-hospital intervention in patients with transient ischemic attacks?

Emergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)

Section Editor Scott E Kasner, MD

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Episode 117 TIA Update

* Contributed equally Xueyuan Liu Min Fang, Departmental sources

2015 Update in Diagnosis and Management of Stroke

Cryptogenic Strokes: Evaluation and Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Supplementary appendix

PFO Management update

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

Open Access The Addition of MRI to CT Based Stroke and TIA Evaluation Does Not Impact One year Outcomes

TIAs and posterior circulation problems


CVA Updates Karen Greenberg, DO, FACOEP. Director Neurologic Emergency Department Crozer Chester Medical Center

Practical Considerations in the Early Treatment of Acute Stroke

NeuroPI Case Study: Anticoagulant Therapy

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Guidelines for Ultrasound Surveillance

Management and Investigation of Ischemic Stroke By Etiology

From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

Lecture Outline: 1/5/14

Game Strategy: High Intensity Statin in Stroke. K.M. Osei MD, MSc Cardiovascular Conference PARMC Feb 24, 2018

How to Evaluate Patients with Cryptogenic Stroke

Alan Barber. Professor of Clinical Neurology University of Auckland

Transient ischemic attack (TIA) is a risk factor for

Guideline scope Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (update)

ORIGINAL CONTRIBUTION. Impact of Abnormal Diffusion-Weighted Imaging Results on Short-term Outcome Following Transient Ischemic Attack

Stroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA

Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke

It is the nature of a stroke to partly take away the use of a man s limbs and to throw him onto the parish if he had no children to look to

STROKE UPDATE ANTHEA PARRY MAY 2010

Vague Neurological Conditions

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Alan Barber. Professor of Clinical Neurology University of Auckland

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Raluca Pavaloiu et al. - Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke

Screening and Management of Blunt Cereberovascular Injuries (BCVI)

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

Characteristics analysis of cerebral vascular angiography from transient ischemic attack accompanied with type 2 diabetes.

Provider Led Entity. CDI Quality Institute PLE Stroke AUC 07/31/2018

Endovascular Treatment Updates in Stroke Care

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Stroke: What did we learn in the last year?

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

Speakers. 2015, American Heart Association 1

Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.

Acute Stroke Protocols Modified- What s New in 2013

Stroke/TIA. Tom Bedwell

Mike Previti, MD UW Valley Medical Center, Stroke Program Medical Director UW, Dept of Neurology, Clinical Instructor

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL

FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema. Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M.

Imaging Modalities in Acute Stroke: Time is Brain

Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

11/1/2018. Disclosure. Imaging in Acute Ischemic Stroke 2018 Neuro Symposium. Is NCCT good enough? Keystone Heart Consultant, Stock Options

Acute Perfusion and Diffusion Abnormalities Predict Early New MRI Lesions 1 Week After Minor Stroke and Transient Ischemic Attack

Subclavian artery Stenting

Dr Ross Keenan. Neuroradiologist Christchurch Hospital

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis

Validation and Refinement of the ABCD2 Score A Population-Based Analysis

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

NQF ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: The Joint Commission Only CMS Voluntary Only

TIA as Acute Cerebrovascular Syndrome

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

Asymptomatic Carotid Stenosis To Do or Not To Do

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Transcription:

Why Should TIA be Treated Emergently? Anne M. Pawlak, D.O. F.A.C.N. Michigan Institute for Neurological Disorders Director Neurology Residency Program, Garden City Hospital, Garden City, Michigan

According to the AHA/ASA scientific statement of June 2009: Large cohort and population-based studies reported in the last five years have demonstrated a higher risk of early stroke after TIA than generally suspected. Ten percent to 15% of patients have a stroke within 3 months with half occurring within 48 hours. Beca se of this high risk patients need to be Because of this, high risk patients need to be stratified early to identify disease and treat it

We need to update our definition, iti urgency, and evaluation There is too much complacency about TIA! We should start thinking about these as the Angina of the Brain

Statisticsti ti Incidence of TIA in the US approximately 200,000 to 500,000/year Prevalence 2.3%; so approximately 5 million people Overall TIA incidence 1.1/1000 people

Definition iti TIA and stroke reflect reduced cerebral blood flow with increased risk for disability and death Traditionally, TIA defined as a sudden, focal neurologic deficit of presumed vascular origin lasting < 24 hours

24 hour time frame arbitrary (mid 1960s) Presumed no permanent brain injury, but with improved imaging this has been disproved!

Frequency of DWI in patients with transient neurological episodes of different durations (3) Duration of symptoms (hours) DWI 0-1 33.6 1-2 29.5 2-3 39.5 3-6 30.0 6-12 51.11 12-18 50.0 18-24 49.5

The new tissue-based definition: iti a transient episode of neurological dysfunction caused by a focal brain, spinal cord, or retinal ischemia, without acute infarction

Time window is arbitary (whether 1 hour or 24 hours) and should use a definition which h is tissue-based, as are most disease definitions in clinical medicine! We have a golden opportunity to avoid wrecking the brain the next 48 hours= URGENCY!

Stratification TIA can portend CVA: short term risk of stroke is particularly high Exceeds 10% in 90 days Particularly high in first few days after TIA One quarter to one half of strokes that occur within 3 months actually occur in the first 2 days This is why we need prompt evaluation and treatment!

ABCD Score predicts short term risk of stroke after TIA (optimized to predict stroke in 2 days after TIA, but also after 90 days)

The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. Why Should TIA be Treated Emergently? Risk Factor Points Age > 60 1 BP: Systolic > 140 mm Hg or Diastolic > 90mm Hg 1 Clinical featureclinical features of TIA: (choose one) Unilateral weakness with or without speech impairment or 2 Speech Impairment without unilateral weakness 1 Duration: TIA > 60 minutes 2 TIA<10-59 minutes 1 Diabetes 1

In combined validation cohorts, the 2-day risk of stroke was 0% for scores 0 or 1, 13%f 1.3% for 2 or 3, 41%f 4.1% for 4 or 5, and d81% 8.1% for 6 or 7

The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location. Why Should TIA be Treated Emergently?

The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location. Why Should TIA be Treated Emergently?

Unfortunately, t these do not incorporate imaging If new infarct on imaging=2-15 fold increase in subsequent short-term risk of fcva If vessel occlusion on MRA=4 fold increase in short-term t risk of stroke

HOSPITALIZATION VERSUS OUTPATIENT EVALUATION 4 or more points on the ABCD score place patients at high risk of imminent stroke Reasonable to hospitalize if present 3-4/7 to initiate evaluation faster to differentiate cause and determine most effective treatment

HOSPITALIZATION VERSUS OUTPATIENT EVALUATION 1-2 outpatient evaluation appropriate but still do promptly SAVE THE BRAIN-THINK THINKOFTHISAS THIS ANGINA OF THE BRAIN

DIAGNOSTIC EVALUATION Goals of neuroimaging: Obtain evidence of a vascular origin Exclude alternative non-ischemic origin Ascertain the underlying vascular mechanism (large versus small vessel, embolic) allowing optimal therapy Identify prognostic outcome

DIAGNOSTIC EVALUATION Goals of neuroimaging MRI, especially diffusion-weighted, permits confirmation of focal ischemia, improves accuracy of vascular localization and cause of TIA, and extent of pre-existing cerebrovascular disease and is considered the preferred diagnostic test

Class I Recommendations (1) Patients with TIA should preferably undergo neuroimaging i evaluation within 24 hours of symptom onset. MRI, including DWI, is the preferred brain diagnostic imaging modality. If MRI not available, head CT should be performed (Class I, Level of Evidence B).

Class I Recommendations (1) Noninvasive imaging of the cervicocephalic vessels should be performed routinely as part of the evaluation of patients with suspected TIAs (Class I, Level of Evidence A)

Class I Recommendations (1) Noninvasive testing of the intracranial vasculature reliably excludes the presence of intracranial stenosis (Class I, Level of Evidence A) and is reasonable to obtain when knowledge of intracranial steno-occlusive occlusive disease will alter management. Reliable diagnosis of the presence and degree of intracranial stenosis requires the performance of catheter t angiography to confirm abnormalities detected with noninvasive testing

Class I Recommendations (1) Patients with suspected TIA should be evaluated as soon as possible after an event (Class I, Level of Evidence B)

Class II Recommendations (1) Initial assessment of the extracranial vasculature may involve any of the following: CUS/TCD, MRA, or CTA, depending on local availability and expertise, and characteristics of the patient (Class IIa, Level of Evidence B) If only noninvasive testing is performed before If only noninvasive testing is performed before endarterectomy, it is reasonable to pursue 2 concordant noninvasive findings; otherwise, catheter angiography should be considered (Class IIa, Level of Evidence B)

Class II Recommendations (1) The role of plaque characteristics and detection of MESs is not yet defined (Class IIb, Level of Evidence B) ECG should occur as soon as possible after TIA (Class I, Level of Evidence B). Prolonged cardiac monitoring (inpatient telemetry or Holter monitor) is useful in patients with an unclear origin after initial brain imaging and electrocardiography (Class IIa, Level of Evidence B)

Class II Recommendations (1) Echocardiography (at least TEE) is reasonable in the evaluation of patients with suspected TIAs, especially in patients in whom no cause has been identified by other elements of the workup (Class IIa, Level of Evidence B). TEE is useful in identifying PFO, aortic arch atherosclerosis, and valvular l disease and is reasonable when identification of these conditions will alter management (Class IIa, Level of Evidence B) Routine blood tests (complete blood count, chemistry panel, prothrombin time and partial thromboplastin time, and fasting lipid panel) are reasonable in the evaluation of patients with suspected TIAs (Class IIa, Level of Evidence B)

Class II Recommendations (1) It is reasonable to hospitalize patients with TIA if they present within 72 hours of the event and any of the following criteria are present ABCD score > or = 3 (Class Ila, Level of Evidence C) ABCD score of 0 to 2 and uncertainty that diagnostic workup can be completed within 2 days as an outpatient (Class IIa, Level of Evidence C) ABCD score of 0 to 2 and other evidence that indicates that the patient's event was caused by focal ischemia i (Class IIa, Level of Evidence C)

INTERESTING FACTS MES=microembolic signals identified with TCD High numbers are a marker of increased risk in patients t with TIA of carotid origin Only 6% of patients had MES within 14 days of symptoms! So not good routinely

INTERESTING FACTS CUS as a stand alone is cost effective for selecting patients for CEA, but refuted by other institutions Contrast-enhanced MRA most accurate for 70-99% stenosis (sensitivity 94%, specificity 93%) compared with US, MRA, CTA (sensitivity 89%, specificity 84%) CUS good initial test but access accuracy!

References (1)Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami, Higashida RT, Claiborne Johnston S, Kidwell CS, Lutsep HL, Miller E, Sacco RL. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009;40:2276-2293. (2)Johnston SC, Rothwell PM, Huynk-Hunyh H n MN, Giles MF, Elkins JS, Sidney S. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet 2007;369:283-292. [slides 12, 14, 15] (3)Shah SH, Saver JL, Kidwell CS, Albers GW, Rothwell PM, Ay H, Koroshetz WJ, Inatomi Y, Uchino M, Demchuk AM, Counts SB, Purroy F, Alvarez-Sabin JS, Sander D, Sander K, Restrepo L, Wityk RJ, Marx JJ, easton JD. A multicenter pooled, patient-level data analysis of diffusion-weighted MRI in TIA patients. Stroke 2007;38:463.